(Q53543929)

English

Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

Phase II clinical studies of denileukin diftitox diphtheria toxin fusion protein in patients with previously treated chronic lymphocytic leukemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

0 references

1 reference

based on heuristic

inferred from title

Arthur E. Frankel

1

object named as

Arthur E Frankel

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

author name string

Asha Surendranathan

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

Jennifer H Black

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

Angela White

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

Kristen Ganjoo

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

Larry D Cripe

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

language of work or name

0 references

publication date

1 May 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

106

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

2158-2164

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

The clinical and epidemiological burden of chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of UnmutatedVHGene in Patients With Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 9011.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of relapsed chronic lymphocytic leukemia by 72-hour continuous infusion or 1-hour bolus infusion of flavopiridol: results from Cancer and Leukemia Group B study 19805.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

CLL immunotoxins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

The interleukin-2 and interleukin-4 receptors studied by molecular modelling

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of interleukin-2 function, production and clinical applications

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21851

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.21851

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/16586495

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53543929&oldid=1424748838"